| Nargis Sadat, MD | |
|
985582 Nebraska Medical Ctr, Omaha, NE 68198-5582 | |
| (402) 552-6222 | |
| Not Available |
| Full Name | Nargis Sadat |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 10 Years |
| Location | 985582 Nebraska Medical Ctr, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306253448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 30413 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health Bergan Mercy | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alegent Health Bergan Mercy Health System | 8224947783 | 6 |
News Archive
Blood alcohol levels below the current legal limit for driving have a significant negative effect on a person's dexterity. Researchers writing in the open access journal BMC Research Notes found that just two single vodka and orange drinks were enough to make senior volunteers struggle at an obstacle avoidance test while walking.
A Flexure-Based Electromagnetic Linear Actuator (FELA) developed by the Singapore Institute of Manufacturing Technology, a research institute of the Agency for Science, Technology and Research, is the only locally-developed innovation featured in the 2014 R&D 100 Awards, an international competition that recognises the 100 most technologically-significant products introduced into the marketplace over the past year.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
Chemical Abstracts Service, the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder, the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive and current research, available only in SciFinder.
› Verified 2 days ago
| Entity Name | Alegent Creighton Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033288923 PECOS PAC ID: 1850285255 Enrollment ID: O20040326000802 |
News Archive
Blood alcohol levels below the current legal limit for driving have a significant negative effect on a person's dexterity. Researchers writing in the open access journal BMC Research Notes found that just two single vodka and orange drinks were enough to make senior volunteers struggle at an obstacle avoidance test while walking.
A Flexure-Based Electromagnetic Linear Actuator (FELA) developed by the Singapore Institute of Manufacturing Technology, a research institute of the Agency for Science, Technology and Research, is the only locally-developed innovation featured in the 2014 R&D 100 Awards, an international competition that recognises the 100 most technologically-significant products introduced into the marketplace over the past year.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
Chemical Abstracts Service, the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder, the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive and current research, available only in SciFinder.
› Verified 2 days ago
| Entity Name | Alegent Health Bergan Mercy Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184897647 PECOS PAC ID: 8224947783 Enrollment ID: O20041012000940 |
News Archive
Blood alcohol levels below the current legal limit for driving have a significant negative effect on a person's dexterity. Researchers writing in the open access journal BMC Research Notes found that just two single vodka and orange drinks were enough to make senior volunteers struggle at an obstacle avoidance test while walking.
A Flexure-Based Electromagnetic Linear Actuator (FELA) developed by the Singapore Institute of Manufacturing Technology, a research institute of the Agency for Science, Technology and Research, is the only locally-developed innovation featured in the 2014 R&D 100 Awards, an international competition that recognises the 100 most technologically-significant products introduced into the marketplace over the past year.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
Chemical Abstracts Service, the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder, the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive and current research, available only in SciFinder.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nargis Sadat, MD 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: (402) 717-5300 | Nargis Sadat, MD 985582 Nebraska Medical Ctr, Omaha, NE 68198-5582 Ph: (402) 552-6222 |
News Archive
Blood alcohol levels below the current legal limit for driving have a significant negative effect on a person's dexterity. Researchers writing in the open access journal BMC Research Notes found that just two single vodka and orange drinks were enough to make senior volunteers struggle at an obstacle avoidance test while walking.
A Flexure-Based Electromagnetic Linear Actuator (FELA) developed by the Singapore Institute of Manufacturing Technology, a research institute of the Agency for Science, Technology and Research, is the only locally-developed innovation featured in the 2014 R&D 100 Awards, an international competition that recognises the 100 most technologically-significant products introduced into the marketplace over the past year.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
Chemical Abstracts Service, the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder, the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive and current research, available only in SciFinder.
› Verified 2 days ago
Dr. David Berman Walker, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10625 Calhoun Rd, Omaha, NE 68112 Phone: 402-457-1300 Fax: 402-457-1403 | |
Dr. Srinivas Dannaram, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Creighton Nebraska, Department Of Psychiatry 985582, Omaha, NE 68198 Phone: 402-552-6244 | |
Albert Matthew Dickan, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7710 Mercy Rd Ste 202, Omaha, NE 68124 Phone: 402-280-4195 | |
Nicole J Bergerson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9239 W Center Rd, Suite 225, Omaha, NE 68124 Phone: 402-505-9550 Fax: 402-614-3414 | |
Ho Taik Sung, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7710 Mercy Road, Suite 202, Cu Department Of Psychiatry, Omaha, NE 68124 Phone: 402-280-4195 | |
Michael L Meyer, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9239 West Center Rd, Suite 205, Omaha, NE 68124 Phone: 402-354-8080 Fax: 402-354-8044 | |
Dr. Frederick Petty, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4101 Woolworth Ave, 116a, Omaha, NE 68105 Phone: 402-346-8800 Fax: 402-449-0677 |